Y Trademark

Trademark Overview


On Wednesday, April 26, 2023, a trademark application was filed for Y with the United States Patent and Trademark Office. The USPTO has given the Y trademark a serial number of 97909021. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, January 23, 2025. This trademark is owned by Prodigy Biotech, Inc.. The Y trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for therapeutic and prophylactic use for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for use in antibacterial treatments, anti-toxin treatments, anti-fungal treatments, anti-yeast treatments, anti-parasite treatments, anti-cytokine treatments, anti-receptor treatments, antibiotic treatments and antiviral treatments, for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for repairing, modifying and modulating the intestinal microbiome; pharmaceutical and biological preparations for repairing, modifying and modulating the intestinal microbiome; pharmaceutical preparations and substances for the treatment ...
y

General Information


Serial Number97909021
Word MarkY
Filing DateWednesday, April 26, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, January 23, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 28, 2024

Trademark Statements


Description of MarkThe mark consists of a stylized design of the letter "Y" within a circle.
Goods and ServicesPharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for therapeutic and prophylactic use for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for use in antibacterial treatments, anti-toxin treatments, anti-fungal treatments, anti-yeast treatments, anti-parasite treatments, anti-cytokine treatments, anti-receptor treatments, antibiotic treatments and antiviral treatments, for humans and animals and for use in aquaculture; pharmaceutical preparations in the nature of IgY antibodies, avian hyperimmune egg product and avian hyperimmune egg yolk product for repairing, modifying and modulating the intestinal microbiome; pharmaceutical and biological preparations for repairing, modifying and modulating the intestinal microbiome; pharmaceutical preparations and substances for the treatment of gut dysbioses, inflammatory disorders and conditions, gastrointestinal diseases and disorders, gastrointestinal injury conditions, and digestive abnormalities; pharmaceutical and therapeutic preparations for use in the prevention and treatment of abnormalities in the human gut microbiome and gastrointestinal health; pharmaceutical preparations for medical, veterinary and aquaculture purposes, namely, antibacterial treatments, anti-toxin treatments, antibiotic treatments and antiviral treatments.
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 24, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameProdigy Biotech, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19382

Party NameProdigy Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19382

Trademark Events


Event DateEvent Description
Monday, May 1, 2023NEW APPLICATION ENTERED
Wednesday, May 24, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 25, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, January 23, 2024ASSIGNED TO EXAMINER
Tuesday, April 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 23, 2024NON-FINAL ACTION WRITTEN
Tuesday, January 23, 2024NON-FINAL ACTION E-MAILED
Tuesday, January 23, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 23, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 24, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 8, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 28, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, January 23, 2025SOU TEAS EXTENSION RECEIVED
Thursday, January 23, 2025SOU EXTENSION 1 FILED
Thursday, January 23, 2025SOU EXTENSION 1 GRANTED
Tuesday, March 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED